Predictive value of lung function measures for cardiovascular risk: a large prospective cohort study
Conclusion
Clinicians could consider spirometry indicators in CVD risk assessment. Cost-effectiveness studies and clinical trials are needed to put new CVD risk assessment into practice.
Source: Thorax - Category: Respiratory Medicine Authors: Zhou, L., Yang, H., Zhang, Y., Wang, Y., Zhou, X., Liu, T., Yang, Q., Wang, Y. Tags: Thorax Respiratory epidemiology Source Type: research
More News: Cardiology | Cardiovascular | Clinical Trials | Epidemiology | Heart | Respiratory Medicine | Spirometry | Study